Developer docs
API playgroundTry for free, no card

Search company profiles

Cellular Technology

Full company profile

uuid000ag1m

Namestring
Cellular Technology
Legal namestring
Cellular Technology Limited
Websiteurl
immunospot.com
Company typeenum
Private
Founded yearint
1999
Descriptiontext

Cellular Technology Limited (CTL) is a US-based life-sciences tools and contract laboratory company founded in 1998/1999 in Ohio, operating under the ImmunoSpot brand. The company specializes in standardized immune monitoring using ELISPOT and FluoroSpot assay technologies, which detect and enumerate antigen-specific T cells and B cells at single-cell resolution for vaccine development, immune-oncology, cell therapy, and translational research applications. Its integrated stack spans high-throughput S6-series analyzers (supporting 1-12 color fluorescence, plus bright-field and colony-counting modalities), proprietary software suites (ImmunoSpot, BioSpot, Fluoro-X) with AI-based IntelliCount and statistics-based SmartCount algorithms, a catalog of standardized kits, serum-free media, cryopreserved characterized PBMC controls, and IQ/OQ plus 21 CFR Part 11 regulatory compliance packages for GxP environments.

CTL monetizes through four streams: (1) one-time enterprise hardware sales of ImmunoSpot and BioSnap analyzers (quote-based, with optional multi-year service contracts), (2) recurring consumable revenue from T cell and B cell kits, detection antibodies, and serum-free media, (3) CRO services spanning whole-blood processing, ELISPOT testing, ELISA, neutralizing antibody assays, flow cytometry, and assay standardization, and (4) sales of cryopreserved characterized PBMC reference samples. Customers are primarily pharmaceutical and biotech companies (vaccine and cell therapy sponsors), academic research institutions, and contract research organizations requiring validated, regulatory-compliant immune monitoring. Approximately 1,000 analyzers operate in regulated environments and thousands have been sold globally.

In April 2026 CTL was acquired by VION Biosciences, becoming a wholly-owned subsidiary while retaining its leadership and ImmunoSpot brand. The company is recognized alongside Mabtech and Oxford Immunotec Global as a dominant player in the ELISPOT and FluoroSpot assay market.

Short descriptiontext

Cellular Technology Limited (CTL) is an Ohio-based life-sciences tools and CRO company that sells ELISPOT/FluoroSpot analyzers, kits, software, and contract testing services for standardized immune monitoring. It serves pharmaceutical and biotech sponsors, academic researchers, and CROs running vaccine, immune-oncology, and cell therapy studies.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersShaker Heights, United States
HQ citystring
Shaker Heights
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
immune monitoring assays, ELISPOT analyzers, FluoroSpot readers, cryopreserved PBMC, contract research services
Industry3 codes
PRIMARYHLAGAEAB
Specialty & Biomarker Laboratory Services (Immunoassays/Flow/Cytometry)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Central Labs & Clinical Diagnostics Services (Trial Support)
SECONDARYHLAGAIAI
Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes)
SECONDARYHLAFAMAB
Clinical Chemistry & Immunoassay Laboratories
NAICS code3 codes
  • Medical and Diagnostic Laboratories62151
  • In-Vitro Diagnostic Substance Manufacturing325413
  • Analytical Laboratory Instrument Manufacturing334516
SIC code3 codes
  • Services-Medical Laboratories8071
  • In Vitro & In Vivo Diagnostic Substances2835
  • Laboratory Analytical Instruments3826
Product category
Laboratory Analytical Instruments
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model5 records
1ImmunoSpot Analyzers
TypeOne Time License
Description

Sale of ELISPOT/FluoroSpot reader instruments including S6 series analyzers, BioSnap analyzers, and automation accessories (ImmunoBot, ImmunoStack). Revenue from initial hardware purchase with optional service contracts.

immunospot.com
2ELISPOT/FluoroSpot Kits and Reagents
TypeSubscription Recurring
Description

Consumable kit sales including T Cell Kits, B Cell Kits, detection antibodies, enzymatic and fluorescent reagents, serum-free media, and control reagents. Recurring revenue from consumable purchases.

immunospot.com
3CRO Services
TypeProfessional Services
Description

Contract research organization services including T Cell/B Cell ELISPOT testing, ELISA, neutralization antibody assays, flow cytometry, sample management, assay standardization, and kit scanning/analysis services.

immunospot.com
4Cryopreserved PBMC
TypeOne Time License
Description

Sale of characterized peripheral blood mononuclear cells including HLA-typed, antigen-specified reactivity, NK-activity characterized, and SARS-CoV-2 characterized samples.

immunospot.com
5Service Contracts and Support
TypeSubscription Recurring
Description

Ongoing service contracts, customer support, training, and consultation services for instrument users.

immunospot.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Technology or R&D, Operations, Supply Chain, Marketing or Sales, Infrastructure
Pricing details1 tier
1Enterprise hardware sales with service contracts
ModelOne time/ perpetual licenseBilling cadenceMulti-year contract
Notes

Analyzers sold as perpetual hardware licenses with optional annual service contracts for support and maintenance. Price inquiry required for all analyzer models.

immunospot.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 4 records shown
1ImmunoSpot®
Description

The company's primary brand platform for ELISPOT and FluoroSpot immune monitoring technology, including analyzers, kits, software, and services.

immunospot.com
+3 more records
Core offering1 text field

CTL designs, manufactures, and sells automated ELISpot and FluoroSpot analyzers (S6 Series, BioSnap) along with ImmunoSpot-branded analysis software, single-color and dual-color T cell and B cell kits, serum-free media, cryopreserved PBMC (ePBMC), and monocyte activation test (MAT) kits. It complements these products with a GLP/GCP-compliant contract laboratory in Shaker Heights, Ohio that runs immune monitoring and immunogenicity assays on a fee-for-service basis for vaccine and immunotherapy developers.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • Detects antigen-specific immune responses as low as 1 in 1,000,000 cells (0.0001% frequency)
+4 more records
Product and service12 records
1S6 Series Analyzers
CategoryImmune Monitoring Analyzers
Description

Automated ELISpot and FluoroSpot analyzers that read single-color and dual-color T cell and B cell immune monitoring assays at high throughput, designed for pharmaceutical, biotech, academic, and government immunology laboratories.

2BioSpot Analyzers
CategoryImmune Monitoring Analyzers
Description

Automated ELISpot and FluoroSpot readers offered alongside the S6 Series as part of CTL's immune monitoring instrument portfolio.

3ImmunoSpot Analysis Software
CategoryAnalysis Software
Description

ImmunoSpot-branded analysis software powered by the proprietary IntelliCount AI spot-counting algorithm, with SmartCount, AutoGate, Live/Dead gates, and dual-color overlays, available in GLP/GCP/CFR Part 11 compliant configurations for regulated environments.

4Fluoro-X Software
CategoryAnalysis Software
Description

Software for CTL's FluoroSpot analyzers that enables multi-color fluorescence spot detection, gating, and analysis.

5TVA Cytotoxicity Suite
CategoryAnalysis Software
Description

Software suite for CTL's T cell cytotoxicity workflows, providing automated analysis of tumor-infiltrating lymphocyte and target cell killing assays.

6T Cell ImmunoSpot Kits
CategoryAssay Kits and Reagents
Description

ELISpot kits for detecting antigen-specific T cell responses across human, non-human primate, mouse, rat, and pig species, used with CTL analyzers and ImmunoSpot software.

7B Cell ImmunoSpot Kits
CategoryAssay Kits and Reagents
Description

ELISpot kits for detecting antigen-specific antibody-secreting B cell responses across human, mouse, pig, and ferret species, used with CTL analyzers and ImmunoSpot software.

8CTL-Test Serum-Free Media
CategoryAssay Kits and Reagents
Description

Serum-free cell culture media (CTL-Test and CTL-Test PLUS) for immune cell culture in ELISpot, FluoroSpot, and related immune monitoring assays.

9Cryopreserved PBMC (ePBMC)
CategoryAssay Kits and Reagents
Description

Cryopreserved peripheral blood mononuclear cells (ePBMC) supplied by CTL as standardized positive-control and reference materials for immune monitoring assays.

10Monocyte Activation Test (MAT) Kits
CategoryAssay Kits and Reagents
Description

In vitro monocyte activation test (MAT) kits for pyrogen and endotoxin testing in pharmaceutical and vaccine quality control release workflows.

11Immune Monitoring CRO Services
CategoryContract Research Services
Description

GLP/GCP-compliant contract laboratory services for ELISpot, FluoroSpot, and immunogenicity assays, delivered from CTL's Shaker Heights, Ohio facility for pharmaceutical, biotech, and academic sponsors.

12Positive Controls (CEF, CPI)
CategoryAssay Kits and Reagents
Description

Positive control peptide pools (e.g., CEF, CPI) used as standardized reference reagents in T cell ELISpot immune monitoring assays.

Scale indicator7 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-04-09
Description

VION Biosciences completed acquisition of Cellular Technology Limited (CTL) in April 2026. The acquisition adds CTL's ELISPOT and FluoroSpot analyzers, regulatory-grade software, matched consumables, and assay services to VION's portfolio, strengthening its position in immune medicine workflow-critical measurement capabilities including vaccine development, immune-oncology, and cell therapy applications. CTL continues operating under existing leadership while benefiting from VION's broader commercial and strategic infrastructure.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Mabtech is a Swedish specialist in ELISPOT and FluoroSpot reagents, kits, and readers and is explicitly named alongside CTL as one of three dominant players in the 2026–2031 ELISpot/FluoroSpot market report. It is the closest direct peer, competing head-to-head with CTL on kits, analyzers, and PBMC reagents.

TypeDirect peer
Description

Oxford Immunotec — now part of Revvity — developed the T-SPOT.TB tuberculosis test on ELISPOT technology and is named as the third dominant player in the ELISpot/FluoroSpot market. It competes with CTL in regulated immune monitoring applications and benefits from Revvity's substantially larger commercial reach.

TypeBroad incumbent
Description

MSD operates a broad electrochemiluminescence-based immunoassay platform used across pharma, biotech, and academic immune monitoring. It overlaps with CTL in immunoassay-based biomarker measurement but serves a wider portfolio of targets beyond T/B cell ELISPOT/FluoroSpot.

TypeBroad incumbent
Description

Bio-Techne (R&D Systems, ProteinSimple, ExoDx) supplies ELISA kits, antibodies, proteins, and reagents used in immune monitoring workflows. It competes with CTL's kits and reagents business and serves overlapping academic and pharma customers, though across a much broader life sciences catalog.

TypeBroad incumbent
Description

Luminex, now part of DiaSorin, provides multiplexed bead-based assay systems (xMAP) widely used in immune monitoring and clinical research. It overlaps with CTL's high-throughput, multi-analyte positioning but operates a broader multiplexed instrument and assay portfolio.

TypeBroad incumbent
Description

BD Biosciences is a global leader in flow cytometry instruments and reagents — directly overlapping with CTL's flow cytometry testing services and broader immune monitoring workflows. It is a much larger incumbent serving the same pharma/biotech and academic customer base.

TypeBroad incumbent
Description

Charles River is a global CRO providing safety assessment, immunology, and cell therapy services to pharma and biotech. It competes with CTL's CRO services arm in immune monitoring, assay standardization, and biologics safety testing (including pyrogen/MAT services).

TypeBroad incumbent
Description

Thermo Fisher operates the broadest life sciences and lab instruments portfolio (including Gibco media, Invitrogen reagents, and CRO services via PPD). It is an indirect peer through overlapping reagents, media, immunoassay kits, and clinical research services used by CTL's customers.

TypeBroad incumbent
Description

Beckman Coulter, a Danaher operating company, manufactures analytical laboratory instruments and reagents including flow cytometry and immunoassay analyzers. It competes with CTL in regulated lab instrumentation and reagent workflows at a much larger scale and broader portfolio.

10Cellero (subsidiary of Astarte Biologics)
TypeEmerging player
Description

Cellero/Astarte Biologics supplies cryopreserved PBMC and characterized immune cell products to immune monitoring researchers, directly competing with CTL's ePBMC product line. It is a smaller, more focused player in the PBMC supply segment of the immune monitoring value chain.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability5 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature10 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Cellular Technology

Laboratory Analytical Instrumentsimmunospot.com

Cellular Technology Limited (CTL) is an Ohio-based life-sciences tools and CRO company that sells ELISPOT/FluoroSpot analyzers, kits, software, and contract testing services for standardized immune monitoring. It serves pharmaceutical and biotech sponsors, academic researchers, and CROs running vaccine, immune-oncology, and cell therapy studies.

What Cellular Technology does

Cellular Technology Limited (CTL) is a US-based life-sciences tools and contract laboratory company founded in 1998/1999 in Ohio, operating under the ImmunoSpot brand. The company specializes in standardized immune monitoring using ELISPOT and FluoroSpot assay technologies, which detect and enumerate antigen-specific T cells and B cells at single-cell resolution for vaccine development, immune-oncology, cell therapy, and translational research applications. Its integrated stack spans high-throughput S6-series analyzers (supporting 1-12 color fluorescence, plus bright-field and colony-counting modalities), proprietary software suites (ImmunoSpot, BioSpot, Fluoro-X) with AI-based IntelliCount and statistics-based SmartCount algorithms, a catalog of standardized kits, serum-free media, cryopreserved characterized PBMC controls, and IQ/OQ plus 21 CFR Part 11 regulatory compliance packages for GxP environments.

CTL monetizes through four streams: (1) one-time enterprise hardware sales of ImmunoSpot and BioSnap analyzers (quote-based, with optional multi-year service contracts), (2) recurring consumable revenue from T cell and B cell kits, detection antibodies, and serum-free media, (3) CRO services spanning whole-blood processing, ELISPOT testing, ELISA, neutralizing antibody assays, flow cytometry, and assay standardization, and (4) sales of cryopreserved characterized PBMC reference samples. Customers are primarily pharmaceutical and biotech companies (vaccine and cell therapy sponsors), academic research institutions, and contract research organizations requiring validated, regulatory-compliant immune monitoring. Approximately 1,000 analyzers operate in regulated environments and thousands have been sold globally.

In April 2026 CTL was acquired by VION Biosciences, becoming a wholly-owned subsidiary while retaining its leadership and ImmunoSpot brand. The company is recognized alongside Mabtech and Oxford Immunotec Global as a dominant player in the ELISPOT and FluoroSpot assay market.

Cellular Technology firmographics

Firmographics
Name
Cellular Technology
Legal name
Cellular Technology Limited
Website
https://immunospot.com
Company type
Private
Founded year
1999
Operating status
Operating
Headcount range
101–250 employees
Short description
Cellular Technology Limited (CTL) is an Ohio-based life-sciences tools and CRO company that sells ELISPOT/FluoroSpot analyzers, kits, software, and contract testing services for standardized immune monitoring. It serves pharmaceutical and biotech sponsors, academic researchers, and CROs running vaccine, immune-oncology, and cell therapy studies.
Ownership category
akta.pro rank

Cellular Technology industry classification

Industry
Product category
Laboratory Analytical Instruments
NAICS
Medical and Diagnostic Laboratories (62151), In-Vitro Diagnostic Substance Manufacturing (325413), Analytical Laboratory Instrument Manufacturing (334516)
SIC
Services-Medical Laboratories (8071), In Vitro & In Vivo Diagnostic Substances (2835), Laboratory Analytical Instruments (3826)
akta.pro industry
PRIMARYHLAGAEAB
Specialty & Biomarker Laboratory Services (Immunoassays/Flow/Cytometry)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Central Labs & Clinical Diagnostics Services (Trial Support)
SECONDARYHLAGAIAI
Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes)
SECONDARYHLAFAMAB
Clinical Chemistry & Immunoassay Laboratories

Keywords

  • Immune monitoring assays
  • ELISPOT analyzers
  • FluoroSpot readers
  • Cryopreserved PBMC
  • Contract research services

Where Cellular Technology is headquartered

Location

Headquarters

HQ city
Shaker Heights
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Cellular Technology business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Technology or R&D, Operations, Supply Chain, Marketing or Sales, Infrastructure

Revenue model

  1. ImmunoSpot Analyzers: Sale of ELISPOT/FluoroSpot reader instruments including S6 series analyzers, BioSnap analyzers, and automation accessories (ImmunoBot, ImmunoStack). Revenue from initial hardware purchase with optional service contracts.
  2. ELISPOT/FluoroSpot Kits and Reagents: Consumable kit sales including T Cell Kits, B Cell Kits, detection antibodies, enzymatic and fluorescent reagents, serum-free media, and control reagents. Recurring revenue from consumable purchases.
  3. CRO Services: Contract research organization services including T Cell/B Cell ELISPOT testing, ELISA, neutralization antibody assays, flow cytometry, sample management, assay standardization, and kit scanning/analysis services.
  4. Cryopreserved PBMC: Sale of characterized peripheral blood mononuclear cells including HLA-typed, antigen-specified reactivity, NK-activity characterized, and SARS-CoV-2 characterized samples.
  5. Service Contracts and Support: Ongoing service contracts, customer support, training, and consultation services for instrument users.

Pricing tiers

ModelBillingPrice
One time/ perpetual licenseMulti-year contractEnterprise hardware sales with service contracts

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Cellular Technology product offering

Product offering

Core offering

CTL designs, manufactures, and sells automated ELISpot and FluoroSpot analyzers (S6 Series, BioSnap) along with ImmunoSpot-branded analysis software, single-color and dual-color T cell and B cell kits, serum-free media, cryopreserved PBMC (ePBMC), and monocyte activation test (MAT) kits. It complements these products with a GLP/GCP-compliant contract laboratory in Shaker Heights, Ohio that runs immune monitoring and immunogenicity assays on a fee-for-service basis for vaccine and immunotherapy developers.

Differentiator

Problem solved

Functional benefit

Brands

  • ImmunoSpot®: The company's primary brand platform for ELISPOT and FluoroSpot immune monitoring technology, including analyzers, kits, software, and services.
  • BioSpot™
  • ImmunoBot™
  • ImmunoStack™

Products and services

  • S6 Series Analyzers Automated ELISpot and FluoroSpot analyzers that read single-color and dual-color T cell and B cell immune monitoring assays at high throughput, designed for pharmaceutical, biotech, academic, and government immunology laboratories.
  • BioSpot Analyzers Automated ELISpot and FluoroSpot readers offered alongside the S6 Series as part of CTL's immune monitoring instrument portfolio.
  • ImmunoSpot Analysis Software ImmunoSpot-branded analysis software powered by the proprietary IntelliCount AI spot-counting algorithm, with SmartCount, AutoGate, Live/Dead gates, and dual-color overlays, available in GLP/GCP/CFR Part 11 compliant configurations for regulated environments.
  • Fluoro-X Software Software for CTL's FluoroSpot analyzers that enables multi-color fluorescence spot detection, gating, and analysis.
  • TVA Cytotoxicity Suite Software suite for CTL's T cell cytotoxicity workflows, providing automated analysis of tumor-infiltrating lymphocyte and target cell killing assays.
  • T Cell ImmunoSpot Kits ELISpot kits for detecting antigen-specific T cell responses across human, non-human primate, mouse, rat, and pig species, used with CTL analyzers and ImmunoSpot software.
  • B Cell ImmunoSpot Kits ELISpot kits for detecting antigen-specific antibody-secreting B cell responses across human, mouse, pig, and ferret species, used with CTL analyzers and ImmunoSpot software.
  • CTL-Test Serum-Free Media Serum-free cell culture media (CTL-Test and CTL-Test PLUS) for immune cell culture in ELISpot, FluoroSpot, and related immune monitoring assays.
  • Cryopreserved PBMC (ePBMC) Cryopreserved peripheral blood mononuclear cells (ePBMC) supplied by CTL as standardized positive-control and reference materials for immune monitoring assays.
  • Monocyte Activation Test (MAT) Kits In vitro monocyte activation test (MAT) kits for pyrogen and endotoxin testing in pharmaceutical and vaccine quality control release workflows.
  • Immune Monitoring CRO Services GLP/GCP-compliant contract laboratory services for ELISpot, FluoroSpot, and immunogenicity assays, delivered from CTL's Shaker Heights, Ohio facility for pharmaceutical, biotech, and academic sponsors.
  • Positive Controls (CEF, CPI) Positive control peptide pools (e.g., CEF, CPI) used as standardized reference reagents in T cell ELISpot immune monitoring assays.

Quantifiable outcome

  • Detects antigen-specific immune responses as low as 1 in 1,000,000 cells (0.0001% frequency)
  • +4 more outcomes

Companies that use Cellular Technology

Customer profile

Segments4 records

Ideal customer profiles3 records

Cellular Technology technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability5 records

Feature10 records

Cellular Technology partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • VION BiosciencescoreStrategic or Co-development Partner · 9 April 2026VION Biosciences completed acquisition of Cellular Technology Limited (CTL) in April 2026. The acquisition adds CTL's ELISPOT and FluoroSpot analyzers, regulatory-grade software, matched consumables, and assay services to VION's portfolio, strengthening its position in immune medicine workflow-critical measurement capabilities including vaccine development, immune-oncology, and cell therapy applications. CTL continues operating under existing leadership while benefiting from VION's broader commercial and strategic infrastructure.

Scale indicators7 records

Recent moves5 records

Expansion highlights6 records

Cellular Technology competitors and assessment

Company assessment

Direct peers

  • Mabtech: Mabtech is a Swedish specialist in ELISPOT and FluoroSpot reagents, kits, and readers and is explicitly named alongside CTL as one of three dominant players in the 2026–2031 ELISpot/FluoroSpot market report. It is the closest direct peer, competing head-to-head with CTL on kits, analyzers, and PBMC reagents.
  • Oxford Immunotec (Revvity): Oxford Immunotec — now part of Revvity — developed the T-SPOT.TB tuberculosis test on ELISPOT technology and is named as the third dominant player in the ELISpot/FluoroSpot market. It competes with CTL in regulated immune monitoring applications and benefits from Revvity's substantially larger commercial reach.

Broad incumbents

  • Meso Scale Diagnostics (MSD): MSD operates a broad electrochemiluminescence-based immunoassay platform used across pharma, biotech, and academic immune monitoring. It overlaps with CTL in immunoassay-based biomarker measurement but serves a wider portfolio of targets beyond T/B cell ELISPOT/FluoroSpot.
  • Bio-Techne: Bio-Techne (R&D Systems, ProteinSimple, ExoDx) supplies ELISA kits, antibodies, proteins, and reagents used in immune monitoring workflows. It competes with CTL's kits and reagents business and serves overlapping academic and pharma customers, though across a much broader life sciences catalog.
  • Luminex (DiaSorin): Luminex, now part of DiaSorin, provides multiplexed bead-based assay systems (xMAP) widely used in immune monitoring and clinical research. It overlaps with CTL's high-throughput, multi-analyte positioning but operates a broader multiplexed instrument and assay portfolio.
  • Becton Dickinson (BD Biosciences): BD Biosciences is a global leader in flow cytometry instruments and reagents — directly overlapping with CTL's flow cytometry testing services and broader immune monitoring workflows. It is a much larger incumbent serving the same pharma/biotech and academic customer base.
  • Charles River Laboratories: Charles River is a global CRO providing safety assessment, immunology, and cell therapy services to pharma and biotech. It competes with CTL's CRO services arm in immune monitoring, assay standardization, and biologics safety testing (including pyrogen/MAT services).
  • Thermo Fisher Scientific: Thermo Fisher operates the broadest life sciences and lab instruments portfolio (including Gibco media, Invitrogen reagents, and CRO services via PPD). It is an indirect peer through overlapping reagents, media, immunoassay kits, and clinical research services used by CTL's customers.
  • Beckman Coulter Life Sciences (Danaher): Beckman Coulter, a Danaher operating company, manufactures analytical laboratory instruments and reagents including flow cytometry and immunoassay analyzers. It competes with CTL in regulated lab instrumentation and reagent workflows at a much larger scale and broader portfolio.

Emerging players

  • Cellero (subsidiary of Astarte Biologics): Cellero/Astarte Biologics supplies cryopreserved PBMC and characterized immune cell products to immune monitoring researchers, directly competing with CTL's ePBMC product line. It is a smaller, more focused player in the PBMC supply segment of the immune monitoring value chain.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

Cellular Technology social profiles

Digital presence

Cellular Technology financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Cellular Technology leadership team

Management profile

Number of profiles

Profiles2 records

Cellular Technology funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Cellular Technology M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cellular Technology

What does Cellular Technology do?

CTL designs, manufactures, and sells automated ELISpot and FluoroSpot analyzers (S6 Series, BioSnap) along with ImmunoSpot-branded analysis software, single-color and dual-color T cell and B cell kits, serum-free media, cryopreserved PBMC (ePBMC), and monocyte activation test (MAT) kits. It complements these products with a GLP/GCP-compliant contract laboratory in Shaker Heights, Ohio that runs immune monitoring and immunogenicity assays on a fee-for-service basis for vaccine and immunotherapy developers.

Is Cellular Technology a public or private company?

Cellular Technology is a private company. It is classified as corporate owned and is currently operating.

When was Cellular Technology founded?

Cellular Technology was founded in 1999. It employs 101 to 250 people.

Where is Cellular Technology based?

Cellular Technology is headquartered in Shaker Heights, United States, in the North America region.

How does Cellular Technology make money?

Five revenue lines are on record. ImmunoSpot Analyzers are the primary driver. The others are ELISPOT/FluoroSpot Kits and Reagents, CRO Services, cryopreserved PBMC and service Contracts and Support.

Who are Cellular Technology's main competitors?

Direct peers on record are Mabtech and Oxford Immunotec (Revvity). Broad incumbents are Meso Scale Diagnostics (MSD), Bio-Techne, Luminex (DiaSorin), Becton Dickinson (BD Biosciences), Charles River Laboratories, Thermo Fisher Scientific and Beckman Coulter Life Sciences (Danaher). Cellero (subsidiary of Astarte Biologics) is listed as an emerging player.

Does Cellular Technology have an API?

No public API is recorded for Cellular Technology.

What industry is Cellular Technology in?

Cellular Technology's product category is Laboratory Analytical Instruments. Its primary akta.pro industry code is HLAGAEAB, Specialty & Biomarker Laboratory Services (Immunoassays/Flow/Cytometry), with a secondary code of HLAGAIAI, Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes). Its NAICS code is 62151 and its SIC code is 8071.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals